Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Effects of Statins on Respiratory Symptoms and Pulmonary Fibrosis in Covid-19 Patients With Diabetes Mellitus: A Longitudinal Multicenter Study Publisher Pubmed



Sadeghdoust M1 ; Aligolighasemabadi F1 ; Dehesh T2 ; Taefehshokr N3 ; Sadeghdoust A4 ; Kotfis K5 ; Hashemiattar A6 ; Ravandi A7 ; Aligolighasemabadi N8 ; Vakili O9 ; Grabarek B10, 11, 12 ; Staszkiewicz R10, 13 ; Los MJ14, 15 ; Mokarram P15 Show All Authors
Authors
  1. Sadeghdoust M1
  2. Aligolighasemabadi F1
  3. Dehesh T2
  4. Taefehshokr N3
  5. Sadeghdoust A4
  6. Kotfis K5
  7. Hashemiattar A6
  8. Ravandi A7
  9. Aligolighasemabadi N8
  10. Vakili O9
  11. Grabarek B10, 11, 12
  12. Staszkiewicz R10, 13
  13. Los MJ14, 15
  14. Mokarram P15
  15. Ghavami S15, 16, 17, 18, 19

Source: Archivum Immunologiae et Therapiae Experimentalis Published:2023


Abstract

The aim of this prospective cohort study was to explore the effect of statins on long-term respiratory symptoms and pulmonary fibrosis in coronavirus disease 2019 (COVID-19) patients with diabetes mellitus (DM). Patients were recruited from three tertiary hospitals, categorized into Statin or Non-statin groups, and assessed on days 0, 28, and 90 after symptoms onset to record the duration of symptoms. Pulmonary fibrosis was scored at baseline and follow-up time points by high-resolution computed tomography scans. Each group comprised 176 patients after propensity score matching. Data analysis revealed that the odds of having cough and dyspnea were significantly higher in the Non-statin group compared to the Statin group during the follow-up period. Overall, there was no significant difference in the change in pulmonary fibrosis score between groups. However, Non-statin patients with > 5 years of DM were more likely to exhibit a significantly higher fibrosis score during the follow-up period as compared to their peers in the Statin group. Our results suggest that the use of statins is associated with a lower risk of developing chronic cough and dyspnea in diabetic patients with COVID-19, and may reduce pulmonary fibrosis associated with COVID-19 in patients with long-term (> 5 years) DM. Graphical Abstract: [Figure not available: see fulltext.]. © 2023, The Author(s).
Other Related Docs
11. Epigenetic Regulation of Autophagy in Gastrointestinal Cancers, Biochimica et Biophysica Acta - Molecular Basis of Disease (2022)